Blog
RSS FeedPosted by Michael Wonder on 08 Feb 2016
NICE issues draft guidance on alirocumab for lipid disorder
8 February 2016 - NICE has published draft guidance not recommending alirocumab (Praluent, Sanofi/Regeneron) as an option for people with high ...
Posted by Michael Wonder on 28 Dec 2015
NICE issues revised draft guidance on ezetimibe for hypercholesterolaemia
24 December 2015 - NICE is reviewing its guidance on ezetimibe (Ezetrol, MSD) for adults with primary (heterozygous-familial and non-familial) hypercholesterolaemia. ...